This Article Full Text Full Text (PDF) Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Blayney, D. W. Search for Related Content PubMed Articles by Blayney, D. W.

Because this article has no abstract, we have provided an extract of the first 100 words of the full text.

Douglas W. Blayney, MD

Clinical practice guidelines are the focus of this issue, those for surveillance after curative therapy for colorectal cancer and for surveillance on deployment of sentinel lymph node (SLN) biopsy as part of the curative therapy for breast cancer. Both topics are the subject of guidelines recently developed by ASCO's Health Services Committee and published in the Journal of Clinical Oncology. The colorectal cancer guidelines contain a major change regarding the use of computed tomography (CT) for surveillance. Patients who are at high risk of recurrence, and who could be candidates for curative-intent surgery at recurrence, . . . [Click for More]